Chevreuse, France

Isabelle Husson

This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc Sante. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isabelle Husson. Retrieved from https://idiyas.com/inventor/isabelle-husson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Isabelle Husson

Introduction

Isabelle Husson is a notable inventor based in Chevreuse, France. She has made significant contributions to the field of pharmaceuticals, particularly with her innovative formulations. Her work focuses on improving the delivery and effectiveness of medications.

Latest Patents

Isabelle Husson holds a patent for a sustained release pharmaceutical formulation. This invention provides a sustained release formulation of ketoprofen, which comprises granules that include a core of ketoprofen and microcrystalline cellulose, along with a coating made of both water-soluble and water-insoluble cellulose derivatives. This formulation aims to enhance the therapeutic effects of ketoprofen while minimizing side effects.

Career Highlights

Isabelle is associated with Rhone-Poulenc Santé, a prominent company in the pharmaceutical industry. Her work there has been instrumental in advancing drug formulation technologies. She has demonstrated a strong commitment to research and development, contributing to the company's reputation for innovation.

Collaborations

Isabelle has collaborated with Gordon T. Simpkin, working together to enhance the effectiveness of pharmaceutical formulations. Their partnership has led to advancements in the field, showcasing the importance of teamwork in scientific research.

Conclusion

Isabelle Husson's contributions to pharmaceutical innovations highlight her expertise and dedication to improving medication delivery systems. Her patent for sustained release formulations exemplifies her commitment to enhancing patient care through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…